Welcome to our dedicated page for CTS Corporation news (Ticker: $CTS), a resource for investors and traders seeking the latest updates and insights on CTS Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CTS Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CTS Corporation's position in the market.
CTS announced their first quarter 2024 results, highlighting operational performance, profitability, and a focus on diversification. Sales were $125.7 million, down 14% year-over-year, with net income at $11 million. The company is committed to future growth through diversifying customer base and maintaining a disciplined capital structure. They maintain guidance of sales between $530 - $570 million and adjusted EPS between $2.10 - $2.35.
